Get started Log in

AGY — Allergy Therapeutics Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapNeutral

Market Cap
£500.27m
Enterprise Value
£516.94m
Revenue
£55.04m

ZQ Capital Limited Allergy Therapeutics - Posting of Offer Document
19/10/2023 07:00
Allergy Therapeutics - Holding(s) in Company
16/10/2023 15:03
ZQ Capital Limited Allergy Therapeutics - Unconditional Mandatory Cash Offer
16/10/2023 08:01
Brief: Allergy Therapeutics Raises Gross Proceeds Of About £40.75 Mln Via Equity Financing
13/10/2023 07:18
Allergy Therapeutics - Result of Open Offer and Subscription
13/10/2023 07:00
Brief: Allergy Therapeutics FY Revenue Fell 16% To 61.0 Million Stg
27/09/2023 07:32
Allergy Therapeutics - Unaudited Preliminary Results 2023
27/09/2023 07:00
Brief: Allergy Therapeutics's Phase I VLP Peanut Protect Trial Progress
26/09/2023 07:26
Brief: Allergy Therapeutics Announces Satisfaction Of FDI Clearance Conditions
22/09/2023 07:29
UK's Allergy Therapeutics falls on funding woes, poor sales outlook
10/08/2023 08:41
Brief: Allergy Therapeutics PLC Says FY Rev Expected To Be 16% Lower At £61.0 Million
10/08/2023 07:42
Allergy Therapeutics - Trading update for the year ended 30 June 2023
10/08/2023 07:00
Brief: Allergy Therapeutics Appoints Shaun Furlong As Chief Financial Officer
10/07/2023 13:32
Allergy Therapeutics - Appointment of Chief Financial Officer
10/07/2023 13:12
Allergy Therapeutics logs record low on lower HY profit
19/06/2023 12:41
Brief: Allergy Therapeutics HY Revenue 18% Lower At £39.9M
19/06/2023 07:10
Allergy Therapeutics - Interim Results and Lifting Suspension in Trading
19/06/2023 07:01
Allergy Therapeutics - Publication of Annual Report and Accounts 2022
19/06/2023 07:00
RCS - Allergy Therapeutics - Allergy Therapeutics shares key findings at EAACI
09/06/2023 07:00
Brief: ZQ Capital Says Skygem & Southern Fox Agreed To Subscribe In Allergy Therapeutics At Issue Price Of 1p/Share
06/04/2023 15:08